Hassan, Khaled A <br/><br/>
Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Apr 2013 
 - 1972-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-12-0370  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Animals<br/>Apoptosis--drug effects<br/>Basic Helix-Loop-Helix Transcription Factors--genetics<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cyclic S-Oxides--pharmacology<br/>Flow Cytometry<br/>Gene Expression Regulation, Neoplastic<br/>Green Fluorescent Proteins--genetics<br/>Homeodomain Proteins--genetics<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Lung Neoplasms--drug therapy<br/>Mice<br/>Mice, Inbred NOD<br/>Mice, Nude<br/>Mice, SCID<br/>Multivariate Analysis<br/>Neoplastic Stem Cells--drug effects<br/>Protein Isoforms--antagonists & inhibitors<br/>Receptors, Notch--antagonists & inhibitors<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Signal Transduction--drug effects<br/>Thiadiazoles--pharmacology<br/>Transcription Factor HES-1<br/>Xenograft Model Antitumor Assays